Suchergebnisse - "Li, Fenglin"

PubPharm (136)

81

Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199

enthalten in: Journal of translational medicine | 2021

von Mao, S. | Ling, Q. | Pan, J. | +11

82

Global, regional, and national burdens of leukemia from 1990 to 2017 : a systematic analysis of the global burden of disease 2017 study

enthalten in: Aging | 2021

von Lin, X. | Wang, J. | Huang, X. | +11

83

Inhibition of CPT1a as a Prognostic Marker can Synergistically Enhance the Antileukemic Activity of ABT199

enthalten in: ResearchSquare.com | 2021

von Mao, S. | Ling, Q. | Pan, J. | +11

84

CPT1B, a Metabolic Molecule, Is Also an Independent Risk Factor in CN-AML

enthalten in: ResearchSquare.com | 2021

von Ling, Q. | Mao, S. | Pan, J. | +9

85

Aeromonas Hydrophila Infection Activates Death Receptor Apoptosis Pathway in the RBCs of Grass Carp (Ctenopharyngodon idellus)

enthalten in: ResearchSquare.com | 2021

von Lu, Z. | Yang, M. | Zhang, K. | +8

86

Inhibition of CPT1a as a Prognostic Marker can Synergistically Enhance the Antileukemic Activity of ABT199

enthalten in: ResearchSquare.com | 2021

von mao, s. | Ling, Q. | Pan, J. | +11

87

Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia

enthalten in: BMC medicine | 2021

von Wang, J. | Pan, J. | Huang, S. | +8

88

Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia

enthalten in: BMC medicine | 2021

von Wang, J. | Pan, J. | Huang, S. | +8

89

Use of Network Pharmacology to Investigate the Mechanism by Which Allicin Ameliorates Lipid Metabolism Disorder in HepG2 Cells

enthalten in: Evidence-based complementary and alternative medicine : eCAM | 2021

von Cheng, B. | Li, T. | Li, F.

90

Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation

enthalten in: Thrombosis and haemostasis | 2021

von Huang, J. | Huang, S. | Ma, Z. | +15